AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021
May 11, 2021
31049_dirs_2021-05-10_778f8082-b241-45aa-b8a2-3456a1b5c823.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-05-06
Reporting Person: Wright Joseph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-06 | Common Stock, No Par Value | M | 5000 | $12.06 | Acquired | 17343 | Direct |
| 2021-05-06 | Common Stock, No Par Value | S | 5000 | $64.75 | Disposed | 12343 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-06 | Non-qualified stock options (right to buy) | $12.06 | M | 5000 | Disposed | 2021-10-04 | Common Stock (5000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $17.27 | 2022-02-13 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (20000) | 20000 | Direct |
| Non-qualified stock options (right to buy) | $28.20 | 2024-04-14 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $44.80 | 2025-03-02 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $55.73 | 2026-03-01 | Common Stock (30000) | 30000 | Direct |
| Non-qualified stock options (right to buy) | $37.71 | 2027-02-26 | Common Stock (16722) | 16722 | Direct |
| Non-qualified stock options (right to buy) | $56.25 | 2028-03-19 | Common Stock (9681) | 9681 | Direct |
Footnotes
F1: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
F2: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
F3: Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
F4: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F5: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F6: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F7: Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
F8: Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.